9 Results for "

Momelotinib

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Momelotinib" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-10961
CAS No.: 1056634-68-4
Purity:  99.37%
Synonyms: CYT387
Target:  

JAK Autophagy Apoptosis

Research Areas:  

Cancer

Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50a of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3.
loading...
    loading...
18
18 Publications Verification
Cat. No.: HY-10962
CAS No.: 1056636-06-6
Purity:  98.06%
Synonyms: CYT387 sulfate salt
Target:  

JAK Autophagy Apoptosis

Research Areas:  

Cancer

Momelotinib sulfate (CYT387 sulfate salt) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, 10-fold selectivity versus JAK3 (IC50=155 nM).
loading...
    loading...
Cat. No.: HY-143444
CAS No.: 1654776-91-6
Purity:  99.63%
JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. JAK-IN-20 shows excellent pharmacokinetics and displays anti-inflammatory efficacy in vivo .
loading...
    loading...
Cat. No.: HY-W064657
CAS No.: 1380317-28-1
Target:  

JAK

Research Areas:  

Others

Momelotinib (dihydrochloride) is a JAK1/JAK2 inhibitor that also antagonizes ACVR1, leading to downregulation of Hepcidin expression and increased availability of iron for erythropoiesis. Momelotinib (dihydrochloride) can reduce transfusion burden and spleen enlargement caused by myelofibrosis, showing potential value in research and application within the field of myelofibrosis .
loading...
    loading...
Cat. No.: HY-10961S8
CAS No.: 2056097-81-3
Synonyms: CYT387-d4 hydrochloride hydrate
Momelotinib-d4 (CYT387-d4) dihydrochloride hydrate is a deuterium labeled Momelotinib (HY-10961). Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50s of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3 .
loading...
    loading...
Cat. No.: HY-10963
CAS No.: 1056636-07-7
Synonyms: CYT387 mesylate
Target:  

JAK Autophagy

Research Areas:  

Cancer

Momelotinib mesylate (CYT387 mesylate) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, appr 10-fold selectivity versus JAK3.
loading...
    loading...
Cat. No.: HY-10961R
CAS No.: 1056634-68-4
Synonyms: CYT387 (Standard)
Research Areas:  

Cancer

Momelotinib (Standard) is the analytical standard of Momelotinib. This product is intended for research and analytical applications. Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50a of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3.
loading...
    loading...
Cat. No.: HY-10962R
CAS No.: 1056636-06-6
Synonyms: CYT387 sulfate salt (Standard)
Research Areas:  

Cancer

Momelotinib (sulfate) (Standard) is the analytical standard of Momelotinib (sulfate). This product is intended for research and analytical applications. Momelotinib sulfate (CYT387 sulfate salt) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, 10-fold selectivity versus JAK3 (IC50=155 nM).
loading...
    loading...
Cat. No.: HY-182093S
N-(Cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide-d4 is the deuterium labeled N-(Cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide.
loading...
    loading...